$0.92
2.94% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US89846A2078
Symbol
SCNX

Trxade Group Inc Stock price

$0.92
+0.08 9.79% 1M
-7.46 89.01% 6M
-5.13 84.78% YTD
-4.44 82.83% 1Y
-10.85 92.18% 3Y
-54.49 98.34% 5Y
-83.18 98.90% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.03 2.94%
ISIN
US89846A2078
Symbol
SCNX
Sector
Industry

Key metrics

Market capitalization $12.08m
Enterprise Value $13.84m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 92.27
P/S ratio (TTM) P/S ratio 80.53
P/B ratio (TTM) P/B ratio 0.14
Dividend yield 0.00%
Last dividend (FY24) $8.96
Revenue growth (TTM) Revenue growth -97.79%
Revenue (TTM) Revenue $150.00k
EBIT (operating result TTM) EBIT $-12.78m
Free Cash Flow (TTM) Free Cash Flow $-7.04m
Cash position $2.05m
EPS (TTM) EPS $-3.79
Short interest 0.31%
Show more

Is Trxade Group Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Trxade Group Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Trxade Group Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Trxade Group Inc:

Buy
100%

Financial data from Trxade Group Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
0.15 0.15
98% 98%
100%
- Direct Costs 0.18 0.18
97% 97%
120%
-0.03 -0.03
103% 103%
-20%
- Selling and Administrative Expenses 13 13
1% 1%
8,460%
- Research and Development Expense - -
-
-
-13 -13
8% 8%
-8,480%
- Depreciation and Amortization 0.06 0.06
95% 95%
40%
EBIT (Operating Income) EBIT -13 -13
1% 1%
-8,520%
Net Profit -15 -15
41% 41%
-10,160%

In millions USD.

Don't miss a Thing! We will send you all news about Trxade Group Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Trxade Group Inc Stock News

Neutral
GlobeNewsWire
one day ago
TAMPA, FL, May 19, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to announce that the U.S. Food and D...
Neutral
GlobeNewsWire
29 days ago
TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to announce the initiation of supp...
Neutral
GlobeNewsWire
about one month ago
TAMPA, FL, April 08, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, announced the divestiture of...
More Trxade Group Inc News

Company Profile

Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; and Other segments. The company operates a Web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a Web-based pharmaceutical marketplace; InventoryRx.com, a Web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, a desktop application, which provides product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; and Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics. Trxade Group, Inc. is based in Land O'Lakes, Florida.

Head office United States
CEO Surendra Ajjarapu
Employees 19
Founded 2005
Website www.scienture.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today